MyCellHub Email Format

Biotechnology ResearchFlanders, Belgium2-10 Employees

Based in Hasselt, Flanders, MyCellHub operates in the biotechnology research sector, offering a toolkit to digitalize, integrate data, and analyze regulated laboratory and cleanroom workflows. The platform supports transforming production reporting away from paper toward digital processes, addressing a common dependency on paper documentation in biotech and biopharmaceutical manufacturing. By enabling digital GMP workflows, the company aims to speed therapeutic development by reducing administrative bottlenecks and enabling faster data-driven decisions. Its target customers are biotech and biopharmaceutical firms that run regulated lab environments and seek to improve data capture and analytics across manufacturing processes. The company positions itself within the regulated biotech manufacturing space, supplying tools to manage digital GMP processes and data integration for compliance. In January 2026, MyCellHub was acquired by Title21 Software, Inc., a Phoenix, Arizona-based provider of enterprise quality management systems and cell and gene therapy orchestration platforms, which also includes its advanced manufacturing execution system platform.

Sign up for free to view info

Company overview Employee directory